124 related articles for article (PubMed ID: 28958621)
1. Cytotoxic properties of the alkaloid rutaecarpine and its oligocyclic derivatives and chemical modifications to enhance water-solubility.
Huang G; Drakopoulos A; Saedtler M; Zou H; Meinel L; Heilmann J; Decker M
Bioorg Med Chem Lett; 2017 Nov; 27(21):4937-4941. PubMed ID: 28958621
[TBL] [Abstract][Full Text] [Related]
2. Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships.
Son JK; Chang HW; Jahng Y
Molecules; 2015 Jun; 20(6):10800-21. PubMed ID: 26111170
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.
Wang B; Mai YC; Li Y; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Apr; 45(4):1415-23. PubMed ID: 20079560
[TBL] [Abstract][Full Text] [Related]
4. Rutaecarpine-inspired scaffold-hopping strategy and Ullmann cross-coupling based synthetic approach: Identification of pyridopyrimidinone-indole based novel anticancer chemotypes.
Yadav M; Roy N; Mandal K; Nagpure M; Santra MK; Guchhait SK
Bioorg Med Chem; 2024 Jul; 109():117799. PubMed ID: 38897138
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis, physicochemical and pharmacological properties of pentacyclic alkaloid-analogues].
Bubenyák M
Acta Pharm Hung; 2011; 81(4):139-49. PubMed ID: 22329301
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1).
Chen Z; Hu G; Li D; Chen J; Li Y; Zhou H; Xie Y
Bioorg Med Chem; 2009 Mar; 17(6):2351-9. PubMed ID: 19254847
[TBL] [Abstract][Full Text] [Related]
7. Progress in the studies on rutaecarpine.
Lee SH; Son JK; Jeong BS; Jeong TC; Chang HW; Lee ES; Jahng Y
Molecules; 2008 Feb; 13(2):272-300. PubMed ID: 18305418
[TBL] [Abstract][Full Text] [Related]
8. Marine Alkaloid Pityriacitrin and Its Analogues: Discovery, Structures, Synthetic Methods and Biological Properties.
Ke S; Xu T; Min Y; Wan Z; Yang Z; Wang K
Mini Rev Med Chem; 2021; 21(2):233-244. PubMed ID: 33200706
[TBL] [Abstract][Full Text] [Related]
9. Bicyclic 1,2,3-triazolium ionic liquids: synthesis, characterization, and application to rutaecarpine synthesis.
Tseng MC; Cheng HT; Shen MJ; Chu YH
Org Lett; 2011 Aug; 13(16):4434-7. PubMed ID: 21797204
[TBL] [Abstract][Full Text] [Related]
10. A flexible synthesis of 2,3-disubstituted indoles from aminobenzyl phosphonium salts. A direct synthesis of rutaecarpine.
Kraus GA; Guo H
J Org Chem; 2009 Aug; 74(15):5337-41. PubMed ID: 19527008
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumoral evaluation of indole alkaloid analogues containing an hexahydropyrrolo[1',2',3':1,9a,9]imidazo[1,2-a]indole skeleton.
Ventosa-Andrés P; González-Vera JA; Valdivielso AM; Teresa García-López M; Herranz R
Bioorg Med Chem; 2008 Oct; 16(20):9313-22. PubMed ID: 18818089
[TBL] [Abstract][Full Text] [Related]
12. New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.
Kim SI; Lee SH; Lee ES; Lee CS; Jahng Y
Arch Pharm Res; 2012 May; 35(5):785-9. PubMed ID: 22644846
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches in the synthesis of batracylin and its analogs: rebirth of an old player?
Dzierzbicka K; Januchta W; Skladanowski A
Curr Med Chem; 2012; 19(26):4475-87. PubMed ID: 22830346
[TBL] [Abstract][Full Text] [Related]
14. Relationships between the structure, cytotoxicity and hydrophobicity of quinazoline derivatives by quantitative structure-activity relationship.
Jantová S; Baláz S; Stankovský S; Spirková K; Lukácová V
Folia Biol (Praha); 1997; 43(2):83-9. PubMed ID: 9158956
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a quinazolinone natural product-templated library with cytotoxic activity.
Liu JF; Kaselj M; Isome Y; Ye P; Sargent K; Sprague K; Cherrak D; Wilson CJ; Si Y; Yohannes D; Ng SC
J Comb Chem; 2006; 8(1):7-10. PubMed ID: 16398546
[No Abstract] [Full Text] [Related]
16. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
17. Gardovatine, a novel Strychnos-Strychnos bisindole alkaloid with cytotoxicity from Gardneria oveta.
Feng T; Li XN; Zhang BH; Li Y; Cai XH; Liu YP; Luo XD
Bioorg Med Chem Lett; 2013 Oct; 23(20):5563-5. PubMed ID: 24012119
[TBL] [Abstract][Full Text] [Related]
18. 2-(2-indolyl-)-4(3H)-quinazolines derivates as new inhibitors of AChE: design, synthesis, biological evaluation and molecular modelling.
Li Z; Wang B; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):583-92. PubMed ID: 22380775
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
Ikeda T; Yaegashi T; Matsuzaki T; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Jan; 21(1):342-5. PubMed ID: 21126872
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and antiproliferative activity screening of (+/-)-aplicyanins A, B and E and related analogues.
Sísa M; Pla D; Altuna M; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2009 Oct; 52(20):6217-23. PubMed ID: 19827832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
